glp-1 drug makers Market Overview: Agonists and the Obesity Market | Blog GLP-1 pills are on the

The most responsible framing is supportive, not curative

Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration

Epub 2012 May 21

Optimal Longevi-D-K2 provides nutrients proven to give complete cardiovascular health support

Formulated with 0.9% benzyl alcohol (9 mg/mL) as a bacteriostatic preservative, it helps inhibit microbial growth, making it ideal for repeated withdrawals when proper sterile technique is followed

Insomnia is a common symptom in those diagnosed with ADHD, as the hyperactive component can make it hard to settle down and rest